Clinical trials
Completed Barrett Esophagus trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 6 |
| 2006 | 4 |
| 2007 | 10 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 12 |
| 2011 | 8 |
| 2012 | 7 |
| 2013 | 6 |
| 2014 | 10 |
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 4 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 110 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mayo Clinic | 27 |
| Massachusetts General Hospital | 8 |
| University of North Carolina, Chapel Hill | 6 |
| National Cancer Institute (NCI) | 5 |
| Case Comprehensive Cancer Center | 4 |
| Columbia University | 4 |
| Medtronic - MITG | 4 |
| University of Michigan | 4 |
| Johns Hopkins University | 3 |
| Lucid Diagnostics, Inc. | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Barrett Esophagus | 110 |
| Gastroesophageal Reflux | 27 |
| Esophageal Neoplasms | 14 |
| Adenocarcinoma | 3 |
| Stomach Neoplasms | 2 |
| Biliary Tract Diseases | 1 |
| Bronchial Neoplasms | 1 |
| Carcinoma | 1 |
| Carcinoma in Situ | 1 |
| Carcinoma, Pancreatic Ductal | 1 |
Trials
Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.